Picture EBD Group BioPharm America 2020 Digital Event BEU2020 650x81
Organisation › Details

Versant Ventures Ventures (Switzerland) GmbH

Versant Ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great healthcare companies. The firm invests across the healthcare sector and at all stages of company development, with an emphasis on the discovery and development of novel therapeutics. With $1.9 billion under management and offices in North America and Europe, Versant has built a team with deep investment, operating, and scientific expertise that enables a hands-on approach to company building. Since the firm's founding in 1999, more than 65 Versant companies have achieved successful acquisitions or IPOs. *


Period Start 2012-03-01 established (approx)
  Group Versant Ventures
Products Industry venture capital
  Industry 2 LIFE SCIENCES
Region Region Basel BS
  Country Switzerland
  Street 36 Aeschenvorstadt
  City 4051 Basel
    Address record changed: 2012-10-10
Basic data Employees n. a.
    * Document for �About Section�: Bayer AG. (12/12/16). "Press Release: Bayer and Versant Ventures Join Forces to Launch Stem Cell Therapy Company BlueRock Therapeutics with USD 225 Million Series A Financing". Leverkusen, et al..
Record changed: 2020-01-11


Picture [iito] No Tracking 650x80px

More documents for Versant Ventures

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

» top